The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Monoclonal Antibody Production Service Market Research Report 2024

Global Monoclonal Antibody Production Service Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1893334

No of Pages : 101

Ask Your Query
Synopsis
Monoclonal antibody production service refers to a specialized laboratory service that involves the production of monoclonal antibodies using various techniques such as cell fusion, immunization, and screening. This service typically involves the preparation of immune cells, fusion of these cells with immortalized cell lines, and screening of antibody-secreting clones to identify monoclonal antibodies that bind specifically to a desired target antigen. The service involves a range of procedures including antibody purification, characterization, and optimization to ensure the production of high-quality antibodies with desired properties.
The global Monoclonal Antibody Production Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for monoclonal antibody production service is towards increased demand in the pharmaceutical and biotechnology industries due to the growing need for advanced therapeutic and diagnostic tools. With the increasing use of monoclonal antibodies in oncology, autoimmune diseases, and other diseases, the need for reliable and efficient production services is increasing. Additionally, the trend towards more sustainable and environmentally friendly research and production methods is contributing to the growth of monoclonal antibody production services, as they reduce the use of harmful chemicals and minimize the environmental impact of antibody production. Furthermore, advancements in technology and bioinformatics are enabling more efficient and accurate production methods that are contributing to the increasing demand for monoclonal antibody production services.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Production Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Production Service.
Report Scope
The Monoclonal Antibody Production Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monoclonal Antibody Production Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoclonal Antibody Production Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bon Opus Biosciences
Biomatik
ProSci, Inc
Sino Biological
Thermo Fisher Scientific
RayBiotech
Cygnus Technologies
Sino Biological
BosterBio
Abeomics
Merck
Cayman Chemical
Hycult Biotech
GenScript
ProMab
R&D Systems
Rockland Immunochemicals
ProteoGenix
Evitria
ProteoGenix
Beijing Abace Biotechnology
Zoonbio Biotechnology
Beijing Biosynthesis Biotechnology
Cusabio
ChinaPeptides
Detaibio
Atagenix Laboratories
Segment by Type
Rabbit Monoclonal Antibodies
Mouse Monoclonal Antibodies
Human Monoclonal Antibodies
Others
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoclonal Antibody Production Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Production Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rabbit Monoclonal Antibodies
1.2.3 Mouse Monoclonal Antibodies
1.2.4 Human Monoclonal Antibodies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Production Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Production Service Market Perspective (2019-2030)
2.2 Monoclonal Antibody Production Service Growth Trends by Region
2.2.1 Global Monoclonal Antibody Production Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Monoclonal Antibody Production Service Historic Market Size by Region (2019-2024)
2.2.3 Monoclonal Antibody Production Service Forecasted Market Size by Region (2025-2030)
2.3 Monoclonal Antibody Production Service Market Dynamics
2.3.1 Monoclonal Antibody Production Service Industry Trends
2.3.2 Monoclonal Antibody Production Service Market Drivers
2.3.3 Monoclonal Antibody Production Service Market Challenges
2.3.4 Monoclonal Antibody Production Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Production Service Players by Revenue
3.1.1 Global Top Monoclonal Antibody Production Service Players by Revenue (2019-2024)
3.1.2 Global Monoclonal Antibody Production Service Revenue Market Share by Players (2019-2024)
3.2 Global Monoclonal Antibody Production Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Production Service Revenue
3.4 Global Monoclonal Antibody Production Service Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Production Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Production Service Revenue in 2023
3.5 Monoclonal Antibody Production Service Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Production Service Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Production Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Production Service Breakdown Data by Type
4.1 Global Monoclonal Antibody Production Service Historic Market Size by Type (2019-2024)
4.2 Global Monoclonal Antibody Production Service Forecasted Market Size by Type (2025-2030)
5 Monoclonal Antibody Production Service Breakdown Data by Application
5.1 Global Monoclonal Antibody Production Service Historic Market Size by Application (2019-2024)
5.2 Global Monoclonal Antibody Production Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Monoclonal Antibody Production Service Market Size (2019-2030)
6.2 North America Monoclonal Antibody Production Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Monoclonal Antibody Production Service Market Size by Country (2019-2024)
6.4 North America Monoclonal Antibody Production Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monoclonal Antibody Production Service Market Size (2019-2030)
7.2 Europe Monoclonal Antibody Production Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Monoclonal Antibody Production Service Market Size by Country (2019-2024)
7.4 Europe Monoclonal Antibody Production Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Production Service Market Size (2019-2030)
8.2 Asia-Pacific Monoclonal Antibody Production Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Monoclonal Antibody Production Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Monoclonal Antibody Production Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Production Service Market Size (2019-2030)
9.2 Latin America Monoclonal Antibody Production Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Monoclonal Antibody Production Service Market Size by Country (2019-2024)
9.4 Latin America Monoclonal Antibody Production Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Production Service Market Size (2019-2030)
10.2 Middle East & Africa Monoclonal Antibody Production Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Monoclonal Antibody Production Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Monoclonal Antibody Production Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bon Opus Biosciences
11.1.1 Bon Opus Biosciences Company Detail
11.1.2 Bon Opus Biosciences Business Overview
11.1.3 Bon Opus Biosciences Monoclonal Antibody Production Service Introduction
11.1.4 Bon Opus Biosciences Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.1.5 Bon Opus Biosciences Recent Development
11.2 Biomatik
11.2.1 Biomatik Company Detail
11.2.2 Biomatik Business Overview
11.2.3 Biomatik Monoclonal Antibody Production Service Introduction
11.2.4 Biomatik Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.2.5 Biomatik Recent Development
11.3 ProSci, Inc
11.3.1 ProSci, Inc Company Detail
11.3.2 ProSci, Inc Business Overview
11.3.3 ProSci, Inc Monoclonal Antibody Production Service Introduction
11.3.4 ProSci, Inc Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.3.5 ProSci, Inc Recent Development
11.4 Sino Biological
11.4.1 Sino Biological Company Detail
11.4.2 Sino Biological Business Overview
11.4.3 Sino Biological Monoclonal Antibody Production Service Introduction
11.4.4 Sino Biological Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.4.5 Sino Biological Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Monoclonal Antibody Production Service Introduction
11.5.4 Thermo Fisher Scientific Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 RayBiotech
11.6.1 RayBiotech Company Detail
11.6.2 RayBiotech Business Overview
11.6.3 RayBiotech Monoclonal Antibody Production Service Introduction
11.6.4 RayBiotech Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.6.5 RayBiotech Recent Development
11.7 Cygnus Technologies
11.7.1 Cygnus Technologies Company Detail
11.7.2 Cygnus Technologies Business Overview
11.7.3 Cygnus Technologies Monoclonal Antibody Production Service Introduction
11.7.4 Cygnus Technologies Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.7.5 Cygnus Technologies Recent Development
11.8 Sino Biological
11.8.1 Sino Biological Company Detail
11.8.2 Sino Biological Business Overview
11.8.3 Sino Biological Monoclonal Antibody Production Service Introduction
11.8.4 Sino Biological Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.8.5 Sino Biological Recent Development
11.9 BosterBio
11.9.1 BosterBio Company Detail
11.9.2 BosterBio Business Overview
11.9.3 BosterBio Monoclonal Antibody Production Service Introduction
11.9.4 BosterBio Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.9.5 BosterBio Recent Development
11.10 Abeomics
11.10.1 Abeomics Company Detail
11.10.2 Abeomics Business Overview
11.10.3 Abeomics Monoclonal Antibody Production Service Introduction
11.10.4 Abeomics Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.10.5 Abeomics Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Monoclonal Antibody Production Service Introduction
11.11.4 Merck Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.11.5 Merck Recent Development
11.12 Cayman Chemical
11.12.1 Cayman Chemical Company Detail
11.12.2 Cayman Chemical Business Overview
11.12.3 Cayman Chemical Monoclonal Antibody Production Service Introduction
11.12.4 Cayman Chemical Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.12.5 Cayman Chemical Recent Development
11.13 Hycult Biotech
11.13.1 Hycult Biotech Company Detail
11.13.2 Hycult Biotech Business Overview
11.13.3 Hycult Biotech Monoclonal Antibody Production Service Introduction
11.13.4 Hycult Biotech Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.13.5 Hycult Biotech Recent Development
11.14 GenScript
11.14.1 GenScript Company Detail
11.14.2 GenScript Business Overview
11.14.3 GenScript Monoclonal Antibody Production Service Introduction
11.14.4 GenScript Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.14.5 GenScript Recent Development
11.15 ProMab
11.15.1 ProMab Company Detail
11.15.2 ProMab Business Overview
11.15.3 ProMab Monoclonal Antibody Production Service Introduction
11.15.4 ProMab Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.15.5 ProMab Recent Development
11.16 R&D Systems
11.16.1 R&D Systems Company Detail
11.16.2 R&D Systems Business Overview
11.16.3 R&D Systems Monoclonal Antibody Production Service Introduction
11.16.4 R&D Systems Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.16.5 R&D Systems Recent Development
11.17 Rockland Immunochemicals
11.17.1 Rockland Immunochemicals Company Detail
11.17.2 Rockland Immunochemicals Business Overview
11.17.3 Rockland Immunochemicals Monoclonal Antibody Production Service Introduction
11.17.4 Rockland Immunochemicals Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.17.5 Rockland Immunochemicals Recent Development
11.18 ProteoGenix
11.18.1 ProteoGenix Company Detail
11.18.2 ProteoGenix Business Overview
11.18.3 ProteoGenix Monoclonal Antibody Production Service Introduction
11.18.4 ProteoGenix Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.18.5 ProteoGenix Recent Development
11.19 Evitria
11.19.1 Evitria Company Detail
11.19.2 Evitria Business Overview
11.19.3 Evitria Monoclonal Antibody Production Service Introduction
11.19.4 Evitria Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.19.5 Evitria Recent Development
11.20 ProteoGenix
11.20.1 ProteoGenix Company Detail
11.20.2 ProteoGenix Business Overview
11.20.3 ProteoGenix Monoclonal Antibody Production Service Introduction
11.20.4 ProteoGenix Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.20.5 ProteoGenix Recent Development
11.21 Beijing Abace Biotechnology
11.21.1 Beijing Abace Biotechnology Company Detail
11.21.2 Beijing Abace Biotechnology Business Overview
11.21.3 Beijing Abace Biotechnology Monoclonal Antibody Production Service Introduction
11.21.4 Beijing Abace Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.21.5 Beijing Abace Biotechnology Recent Development
11.22 Zoonbio Biotechnology
11.22.1 Zoonbio Biotechnology Company Detail
11.22.2 Zoonbio Biotechnology Business Overview
11.22.3 Zoonbio Biotechnology Monoclonal Antibody Production Service Introduction
11.22.4 Zoonbio Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.22.5 Zoonbio Biotechnology Recent Development
11.23 Beijing Biosynthesis Biotechnology
11.23.1 Beijing Biosynthesis Biotechnology Company Detail
11.23.2 Beijing Biosynthesis Biotechnology Business Overview
11.23.3 Beijing Biosynthesis Biotechnology Monoclonal Antibody Production Service Introduction
11.23.4 Beijing Biosynthesis Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.23.5 Beijing Biosynthesis Biotechnology Recent Development
11.24 Cusabio
11.24.1 Cusabio Company Detail
11.24.2 Cusabio Business Overview
11.24.3 Cusabio Monoclonal Antibody Production Service Introduction
11.24.4 Cusabio Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.24.5 Cusabio Recent Development
11.25 ChinaPeptides
11.25.1 ChinaPeptides Company Detail
11.25.2 ChinaPeptides Business Overview
11.25.3 ChinaPeptides Monoclonal Antibody Production Service Introduction
11.25.4 ChinaPeptides Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.25.5 ChinaPeptides Recent Development
11.26 Detaibio
11.26.1 Detaibio Company Detail
11.26.2 Detaibio Business Overview
11.26.3 Detaibio Monoclonal Antibody Production Service Introduction
11.26.4 Detaibio Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.26.5 Detaibio Recent Development
11.27 Atagenix Laboratories
11.27.1 Atagenix Laboratories Company Detail
11.27.2 Atagenix Laboratories Business Overview
11.27.3 Atagenix Laboratories Monoclonal Antibody Production Service Introduction
11.27.4 Atagenix Laboratories Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.27.5 Atagenix Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock